Yeganeh Reuven — SEC Form 4 filings

SEC reporting owner CIK 2044677. 4 Form 4 filings on record with FilingPulse; latest filed 2026-03-18.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-12-20 to 2026-03-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BiomX Inc. (PHGE)Director, 10% owner24 legs · 1,650,000 sh · $8,250,00011
Nukkleus Inc. (NUKK)Director22

Form 4 filings — Yeganeh Reuven

FiledFormIssuerReported transactionsSource
2026-03-184BiomX Inc. (PHGE)Conversion (C): 450,000 @ $2 · Sale (S): 450,000 @ $5 · Conversion (C): 530,000 @ $2 · Sale (S): 530,000 @ $5 · Conversion (C): 900 (derivative) @ $0 · Conversion (C): 1,060 (derivative) @ $0 · +3 moreEDGAR
2026-03-134BiomX Inc. (PHGE)Conversion (C): 300,000 @ $2 · Sale (S): 300,000 @ $5 · Conversion (C): 370,000 @ $2 · Sale (S): 370,000 @ $5 · Conversion (C): 600 (derivative) @ $0 · Conversion (C): 740 (derivative) @ $0EDGAR
2025-11-204Nukkleus Inc. (NUKK)Grant/award (A): 10,000 @ $0EDGAR
2024-12-204Nukkleus Inc. (NUKK)Grant/award (A): 10,000 @ $1.39EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2044677 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →